NCT03478774View on ClinicalTrials.gov

Physiology Regarding Apnoeic Oxygenation During Nasal Cannula Therapy at Different Flow Rates

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Apnoeic Oxygenation
Interventions
DRUG

Oxygen 70l/min

HFNCT will be provided using OptiFlow by Fisher\&Paykel.

DRUG

Oxygen 10 l/min

Medium flow will be applied with a humidifier (Hudson RCI) and a standard nasal cannula.

DRUG

Oxygen 2l/min

Low flow will be applied with a humidifier (Hudson RCI) and a standard nasal cannula.

PROCEDURE

Jaw thrust

Continuous

PROCEDURE

Videolaryngoscopy

Continuous

DRUG

oxygen 0.25l/min

0.25l/min of oxygen via an endotracheal tube

Trial Locations (1)

3008

University Hospital Inselspital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03478774 - Physiology Regarding Apnoeic Oxygenation During Nasal Cannula Therapy at Different Flow Rates | Biotech Hunter | Biotech Hunter